GNH USA

Europe — EMA

Brivudina Doc

GNH USA supplies Brivudina Doc (Brivudine), a nucleoside analog antiviral for herpes infections. Request a quote for global supply.

Brivudine

Request sourcing

1
Pack/s

What is Brivudine?

Brivudine, the active ingredient in Brivudina Doc, is a nucleoside analog antiviral presented as a 125mg tablet for oral use. It is primarily used for the treatment of herpes infections, including herpes zoster and herpes simplex. GNH USA supplies Brivudina Doc as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies, and clinics worldwide.

Brivudina Doc is designed to inhibit the replication of the virus, helping to reduce symptoms and speed up recovery. It is taken orally and is designed to target the underlying cause of the infection.

What is Brivudine used for?

Brivudina Doc is an antiviral medication used to treat herpes infections. It is effective in managing various conditions related to viral infections.

- Herpes zoster (shingles): Reduces the severity and duration of symptoms associated with shingles. - Herpes simplex: Helps in managing outbreaks of herpes simplex infections. - Postherpetic neuralgia: May reduce the risk of developing chronic pain after shingles.

What are the side effects of Brivudine?

Brivudina Doc, like all medications, can cause side effects, although not everyone gets them. Common Side Effects: - Nausea - Headache - Fatigue - Diarrhea - Rash Serious or Rare Side Effects: - Severe allergic reactions - Liver toxicity - Bone marrow suppression - Neurological symptoms such as confusion or seizures

What precautions apply to Brivudine?

Brivudina Doc should be used with caution and under the supervision of a healthcare provider. Consult a healthcare provider before using this medication. Always store Brivudine in a cool, dry place away from direct sunlight. Store below 25°C: keep in the original pack, protect from moisture.

What does Brivudine interact with?

Brivudina Doc can interact with other medications, which may affect its efficacy or increase the risk of side effects. Major Interactions (Avoid): - Fluoropyrimidines: Can increase the risk of severe toxicity. - 5-Fluorouracil: Can lead to significant adverse reactions. Moderate Interactions (Monitor Closely): - Immunosuppressants: May increase the risk of infections. - Antiviral medications: May require dosage adjustments.

Frequently asked questions

What is Brivudina Doc used for?+
Brivudina Doc is used to treat herpes infections, including herpes zoster (shingles) and herpes simplex. It helps reduce the severity and duration of symptoms associated with these infections.
How does Brivudine work?+
Brivudine works by inhibiting viral DNA polymerase after intracellular phosphorylation to its triphosphate form. This action blocks viral DNA synthesis, preventing the virus from replicating and spreading within the body.
What is the usual dose of Brivudina Doc?+
The dosage of Brivudina Doc is determined by a healthcare provider based on the patient's condition and response to treatment. It is typically taken as one tablet once a day for seven days.
Is Brivudina Doc safe during pregnancy or breastfeeding?+
Pregnant or breastfeeding women should consult a healthcare provider before using Brivudina Doc. The safety of the medication during pregnancy and breastfeeding has not been fully established.
How do I order Brivudina Doc from GNH USA?+
To order Brivudina Doc from GNH USA, submit an enquiry on the product page at gnh-usa.com with the required quantity. GNH USA supplies hospitals, pharmacies, and procurement teams across international markets and will ask the buyer to confirm trade or institutional credentials. The team will reply with pricing, availability, shipping, and the import paperwork.
How does Brivudina Doc compare to other antiviral medications?+
Brivudina Doc is specifically indicated for herpes infections and is known for its efficacy in reducing the severity and duration of symptoms. It is important to follow the prescribed dosage and administration instructions provided by a healthcare provider.
How should Brivudina Doc be stored and handled?+
Brivudina Doc should be stored in a cool, dry place away from direct sunlight. Store below 25°C: keep in the original pack, protect from moisture.
How is Brivudina Doc administered?+
Brivudina Doc is taken orally, typically as one tablet once a day for seven days. It is important to follow the prescribed dosage and administration instructions provided by a healthcare provider.
What are the most serious risks to watch for with Brivudina Doc?+
The most serious risks associated with Brivudina Doc include severe allergic reactions, liver toxicity, bone marrow suppression, and neurological symptoms such as confusion or seizures. Patients should seek medical attention if they experience any of these symptoms.
Who should not use Brivudina Doc?+
Patients with a known allergy to Brivudine or any of the excipients in Brivudina Doc should not use this medication. Additionally, patients with pre-existing liver or bone marrow conditions should consult a healthcare provider before using Brivudina Doc.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Brivudine
Route
Oral Use
Manufacturer
Doc Generici S.R.L.
Origin
EU

Related products

A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU
A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU
A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU
A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU